Amennai Beyeen
Analyst-Equity chez Rhenman & Partners Asset Management AB
Profil
Dr. Amennai Beyeen is an Analyst at Rhenman & Partners Asset Management AB.
He has15 years of experience in medical positions within the life science industry.
Dr. Beyeen was previously employed as a Principal by Novartis Pharma (Sweeden) and a Principal by GlaxoSmithKline AB.
He received his graduate degree from Karolinska Institutet and a doctorate degree from Karolinska Institutet.
Postes actifs de Amennai Beyeen
| Sociétés | Poste | Début |
|---|---|---|
Rhenman & Partners Asset Management AB
 Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Analyst-Equity | 01/04/2023 |
Anciens postes connus de Amennai Beyeen
| Sociétés | Poste | Fin |
|---|---|---|
| Novartis Pharma (Sweeden) | Corporate Officer/Principal | 01/04/2023 |
GlaxoSmithkline AB
 GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AB is a Swedish pharmaceutical company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01/07/2005 |
Formation de Amennai Beyeen
| Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Finance |
GlaxoSmithkline AB
GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AB is a Swedish pharmaceutical company that manufactures pharmaceutical products. | Health Technology |
| Novartis Pharma (Sweeden) |